On the morning of January 12, 2017, join Women In Bio and Bloomberg Intelligence for a half-day event following the conclusion of the JP Morgan conference. The event will kick off with a WIB members breakfast (click here to register) followed by two panel discussions. Our panel discussion will feature leaders in the biotech and investment industries, who will detail how federal policy changes in 2017 will shape biotech funding over the next few years. This event will be a great chance to reflect on the 2017 JP Morgan conference, mingle with leaders in the biotech funding space, and interact with WIB members from across the country.
"Early stage investing and fund raising in biotech" panelists:
Moderated by: Caroline Chen, Reporter, Bloomberg News
Brief Remarks from Robin Washington, CFO, Gilead
"Market trends in biotech and pharma: What is in store for 2017?" panelists:
Moderated by: Asthika Goonewardene, Senior Biotech Analyst, Bloomberg Intelligence
- Yi Larson, VP, Goldman Sachs
- Katja Lange, VP, JP Morgan
- Christiana Bardon, Portfolio Manager, Burrage Capital
- Gisela Schwab, CMO, Exelixis
- Carol Gallagher, Partner, New Enterprise Associates
Walk-ins are not accepted – be sure to register early!
10:00 a.m. – 10:50 a.m.
"Early stage investing and fund raising in Biotech"
| 11:00 a.m. – 11:15 a.m.
| Brief Remarks from Robin Washington
11:15 a.m. – 12:00 p.m.
"Market trends in biotech and pharma: What is in store for 2017?"
12:00 p.m. – 1:30 p.m.
Luncheon and Networking
January 11, 2017
Thursday, January 12, 2017
10:00 a.m. – 1:30 p.m. PST